Parkes, David G.
7 papers on CoChat
Most cited papers
- Verified
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
Roth, J. D., Roland, B. L., Cole, R. L., Trevaskis, J. L., Weyer, C., Koda, J. E., Anderson, C. M., Parkes, D. G., & Baron, A. D. (2008) · Proceedings of the National Academy of Sciences
Regulation of Appetite and ObesityPharmacology and Obesity Treatment
Cited by 436
- Verified
GLP ‐1 receptor activated insulin secretion from pancreatic β‐cells: mechanism and glucose dependence
Meloni, A. R., DeYoung, M. B., Lowe, C., & Parkes, D. G. (2013) · Diabetes, Obesity and Metabolism
Pancreatic function and diabetesDiabetes Treatment and Management
Cited by 407
- Verified
Amylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews
Regulation of Appetite and ObesityDiabetes Treatment and Management
Cited by 400
- Verified
Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
Trevaskis, J. L., Griffin, P. S., Wittmer, C., Neuschwander-Tetri, B. A., Brunt, E. M., Dolman, C. S., Erickson, M. R., Napora, J., Parkes, D. G., & Roth, J. D. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology
Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management
Cited by 277
- Verified
GLP‐1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities
Roth, J. D., Erickson, M. R., Chen, S., & Parkes, D. G. (2012) · British Journal of Pharmacology
Diabetes Treatment and ManagementRegulation of Appetite and Obesity
Cited by 74
- Verified
No evidence of drug‐induced pancreatitis in rats treated with exenatide for 13 weeks
Tatarkiewicz, K., Belanger, P., Gu, G., Parkes, D., & Roy, D. (2013) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementPancreatitis Pathology and Treatment
Cited by 56
- Verified
Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis
Nestor, J. J., Parkes, D., Feigh, M., Suschak, J. J., & Harris, M. S. (2022) · Scientific Reports
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 53
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free